Literature DB >> 17630932

Prevention of ischemic stroke: overview of traditional risk factors.

José Rafael Romero1.   

Abstract

Stroke prevails as a common and devastating disease. Epidemiological studies have advanced our understanding of stroke risk factors and clinical trials have demonstrated effective interventions to decrease stroke risk by modifying risk factors. Stroke risk factors are classified as traditional and novel and may be further divided into modifiable and non-modifiable. In this review we discuss select traditional risk factors for ischemic stroke, interventions for primary and secondary prevention and areas of research progress. Stroke treatment should be comprehensive, involving patient, community and medical personnel education, evaluation of individual risk factors and overall stroke risk assessment. Ongoing research is exploring further interventions in the management of traditional risk factors. Future research will expand our knowledge about the contribution of genetic factors to stroke, their interaction with environmental factors and open exciting avenues for the development of new therapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17630932     DOI: 10.2174/138945007781077373

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  8 in total

1.  Cerebral infarction in POEMS syndrome: incidence, risk factors, and imaging characteristics.

Authors:  S A Dupont; A Dispenzieri; M L Mauermann; A A Rabinstein; R D Brown
Journal:  Neurology       Date:  2009-10-20       Impact factor: 9.910

2.  Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later.

Authors:  Alina Solomon; Miia Kivipelto; Benjamin Wolozin; Jufen Zhou; Rachel A Whitmer
Journal:  Dement Geriatr Cogn Disord       Date:  2009-08-04       Impact factor: 2.959

Review 3.  Roles of NAD (+) , PARP-1, and Sirtuins in Cell Death, Ischemic Brain Injury, and Synchrotron Radiation X-Ray-Induced Tissue Injury.

Authors:  Weihai Ying
Journal:  Scientifica (Cairo)       Date:  2013-12-10

Review 4.  Angiogenesis in Ischemic Stroke and Angiogenic Effects of Chinese Herbal Medicine.

Authors:  Sai-Wang Seto; Dennis Chang; Anita Jenkins; Alan Bensoussan; Hosen Kiat
Journal:  J Clin Med       Date:  2016-06-06       Impact factor: 4.241

5.  Peperomia pellucida (L.) Kunth as an angiotensin-converting enzyme inhibitor in two-kidney, one-clip Goldblatt hypertensive rats.

Authors:  Fadlina Chany Saputri; Irma Hutahaean; Abdul Mun'im
Journal:  Saudi J Biol Sci       Date:  2021-06-30       Impact factor: 4.219

6.  Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events.

Authors:  Venkatesh Mani; Paul Muntner; Samuel S Gidding; Silvia H Aguiar; Hamza El Aidi; Karen B Weinshelbaum; Hiroaki Taniguchi; Rob van der Geest; Johan H C Reiber; Sameer Bansilal; Michael Farkouh; Valentin Fuster; John E Postley; Mark Woodward; Zahi A Fayad
Journal:  J Cardiovasc Magn Reson       Date:  2009-04-24       Impact factor: 5.364

Review 7.  The emerging agenda of stratified medicine in neurology.

Authors:  Paul M Matthews; Paul Edison; Olivia C Geraghty; Michael R Johnson
Journal:  Nat Rev Neurol       Date:  2013-12-10       Impact factor: 42.937

8.  Inhibition of angiotensin-converting enzyme activity by flavonoids: structure-activity relationship studies.

Authors:  Ligia Guerrero; Julián Castillo; Mar Quiñones; Santiago Garcia-Vallvé; Lluis Arola; Gerard Pujadas; Begoña Muguerza
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.